Write in a clean editor, then format for Journal of Infection and Public Health in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Infection and Public Health is a peer-reviewed journal published by Elsevier, covering Antibiotic Resistance in Bacteria, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Infection and Public Health 12 (2023) 45–58.
Formats any DOI in Journal of Infection and Public Health style. No sign-up. |
| Publishes research in | Antibiotic Resistance in Bacteria COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Antibiotic Use and Resistance Tuberculosis Research and Epidemiology |
| ISSN | 1876-0341 |
| Citation impact (2-yr) | 3.44 |
| h-index | 100 |
| i10-index | 1,593 |
| Total citations | 73,473 |
| Article processing charge | $1,250 |
| Open access | Yes |
| Top institutions publishing here | King Saud University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed…
Antibiotics have been used to cure bacterial infections for more than 70 years, and these low-molecular-weight bioactive agents have also been used for a variety of other medicinal applications. In the battle against microbes, antibiotics have certainly been a blessing to human civilization by saving millions of lives. Globally, infections caused by multidrug-resistant (MDR) bacteria…
The pandemic situation with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus disease 2019 (COVID-19) is presented with asymptomatic, mild, or severe pneumonia-like symptoms. COVID-19 patients with diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular diseases (CVD), hypertension, malignancies, HIV, and other comorbidities could develop a life-threatening…
The outbreak of COVID-19 has created a global public health crisis. Little is known about the protective factors of this infection. Therefore, preventive health measures that can reduce the risk of infection, progression and severity are desperately needed. This review discussed the possible roles of vitamin D in reducing the risk of COVID-19 and other…
